Email Alerts

Ok Enough Already

Before we get going today a few housekeeping items- 1. We’ve received several questions about The Wacky World of Diabetes podcasts, which by the way are growing in popularity. NO, you do not have to be a subscriber to listen to them and yes, they are available on the site www.diabeticinvestor.com. Yes, you can share them and not violate our copyright. 2. Our special report The Convergence of Forces is NOT included...

Give them what they want

Before we get into today’s post a correction the other day, we mistakenly stated that OneDrop had a relationship with Ascensia when we should have said Bayer. Sorry about that. Ok onto business and the business at hand today is a simple one as everyone continues to develop platforms for helping patients to better manage their diabetes, we’re curious if anyone bothered to ask patients if they want this help. We...

And on it goes

Not like we needed any additional evidence that CGM has become the standard for glucose measurement but check this out “One Drop, a leader in precision health solutions for people living with chronic conditions, today announced Carrie Siragusa, CPA, as VP of Commercial Strategy. Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities...

Fix it, sell it or pass it on

When a large company has a problem with a unit they basically have three choices. They can either fix it, sell it or make it someone else’s problem by passing it on. Our friends at Medtronic have attempted to fix the problems they themselves created for their diabetes unit. Since that has failed they are now taking steps to make the unit sellable. Step one in this process is taking...

Nothing new here

There are times we sit back and wonder what all the fuss is about. We’ve been having these moments a lot lately especially in the digital/virtual health market. And not to get off track should we not come up with a new term that encompasses digital/virtual into one phrase perhaps maybe disease management with new technology or is that too old school. But things are pretty much playing out as...

A sign of things to come?

Before we get into business a little shameless self-promotion but self-promotion for some very worthy organizations. Some of you are aware of my past efforts at raising money while doing a triathlon. This year given I haven’t been able to race because of Covid I decided to do something a little different. First I am raising money for THREE charities – Beyond Type 1 – Homeless Veterans in San Diego...

The Rules

Ok we’re getting just a little irked at all these CGM, OmniPod and Tyler wannabes. So in an effort to separate the real from the imagined we have created some rules for these companies. See we get lots of inquiries from these start up toy companies most of whom that don’t stand an ice cubes chance in hell of ever becoming a commercially viable toy company. Yet each one has...

What matters, what doesn’t

When it comes to the toys in the toy chest there is no better conference than ATTD and while virtual this year once again the diabetes device world is going gaga this week. Dexcom revealed more details about the G7, Medtronic released more data on hybrid closed loop and Senseonics data on their longer term sensor. As valuable as this information may be the question is does it matter all...

Does it matter?

One day someone will have to explain to us how a company that once dominated a market only to screw it up because of their own arrogance should be given the benefit of the doubt. This is basically what Medtronic is asking investors to do when it comes to their still struggling diabetes unit. They want to be given yet another chance as this is not the first not even...

a

News, notes and other things

While the FDA continues to deal with the backlog created by Covid things in Europe seem to be moving a bit quicker. Today Medtronic announced they have obtained CE marks for their Guardian 4 sensor plus expanded functionality for their InPen system. Per a company issued press release; “Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Mark for expanded functionality of the company's InPen™ smart2...